z-logo
open-access-imgOpen Access
Killing of Cryptosporidium sporozoites by Lactoferrin
Author(s) -
José Luis Paredes,
Hayley Sparks,
A. Clinton White,
Griselle Martinez-Traverso,
Theresa J. Ochoa,
Alejandro Castellanos-González
Publication year - 2017
Publication title -
american journal of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.015
H-Index - 151
eISSN - 1476-1645
pISSN - 0002-9637
DOI - 10.4269/ajtmh.16-0804
Subject(s) - lactoferrin , cryptosporidium , cryptosporidium parvum , microbiology and biotechnology , diarrhea , biology , antimicrobial , parasite hosting , immunology , medicine , feces , biochemistry , world wide web , computer science
Intestinal infection caused by Cryptosporidium is a major contributor to diarrhea morbidity and mortality in young children around the world. Current treatments for children suffering from cryptosporidiosis are suboptimal. Lactoferrin is a glycoprotein found in breast milk. It has showed bacteriostatic and antimicrobial activity in the intestine. However, the effects of lactoferrin on the intestinal parasite Cryptosporidium have not been reported. In this study, we investigated the anticryptosporidial activity of human lactoferrin on different stages of Cryptosporidium . Physiologic concentrations of lactoferrin killed Cryptosporidium parvum sporozoites, but had no significant effect on oocysts viability or parasite intracellular development. Since sporozoites are essential for the infection process, our data reinforce the importance of breastfeeding and point to the potential of lactoferrin as a novel therapeutic agent for cryptosporidiosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom